US Patent 10869869 Method of adjuvant cancer treatment
Patent 10869869 was granted and assigned to Novartis on December, 2020 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
October 28, 2019
0
Date of Patent
December 22, 2020
0
Patent Applicant
Patent Application Number
16664978
0
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 10869869 Method of adjuvant cancer treatment
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.